Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Tissue Transplantation01:24

Tissue Transplantation

358
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS Trial.

Blood advances·2026
Same author

Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.

Journal of human immunity·2026
Same author

COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection.

Research square·2026
Same author

Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: Electronic Health Record-Based Descriptive Study.

JMIR medical informatics·2026
Same author

The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic Context.

HLA·2026
Same author

Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial.

Blood advances·2026

Related Experiment Video

Updated: Jun 26, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.8K

Optimal Donor Selection Across Multiple Outcomes For Hematopoietic Stem Cell Transplantation By Bayesian

Rodney A Sparapani1, Martin Maiers2, Stephen R Spellman2

  • 1Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.

Medrxiv : the Preprint Server for Health Sciences
|May 20, 2024
PubMed
Summary

Choosing the best donor for hematopoietic cell transplantation (HCT) is complex. Our study suggests prioritizing the youngest male donor, unless a female donor is significantly younger, to improve survival outcomes.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.8K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

11.9K

Related Experiment Videos

Last Updated: Jun 26, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.8K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.8K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

11.9K

Area of Science:

  • Hematology
  • Immunology
  • Biostatistics

Background:

  • Allogeneic hematopoietic cell transplantation (HCT) offers curative potential for hematologic malignancies but faces challenges from donor selection complexities.
  • Standard HLA gene matching is established, but optimal selection among 8/8 allele-matched unrelated donors requires prioritizing additional factors like HLA-DPB1/DQB1, donor sex, CMV status, and age.
  • Donor characteristics influence various post-transplant outcomes, including survival, relapse, graft failure, and chronic graft-versus-host disease, impacting overall event-free survival (EFS).

Approach:

  • Developed a general methodology using Bayesian nonparametric machine learning to model trade-offs between multiple outcomes for optimal treatment decisions.
  • Applied this approach to HCT donor selection, utilizing a large registry dataset from the Center for International Blood and Marrow Transplant Research (CIBMTR).
  • The model aims to optimize both overall survival and event-free survival (EFS) by considering complex donor attributes.

Key Points:

  • Identified a data-driven donor selection strategy balancing multiple post-transplant outcomes.
  • The methodology addresses the variability in donor selection practices across different centers and patient cases.
  • Bayesian nonparametric machine learning provides a robust framework for optimizing complex medical decisions with multiple competing objectives.

Conclusions:

  • The proposed approach recommends a donor selection strategy favoring the youngest male donor.
  • An exception is made when a female donor is substantially younger, indicating a potential for better outcomes.
  • This data-driven strategy aims to enhance patient survival and event-free survival in allogeneic HCT.